Hypoglycemia in a 40-Year-Old Female - Clinical Evaluation

Step 1 - Confirm Hypoglycemia: Whipple's Triad

1. Symptoms and/or signs of hypoglycemia (autonomic: sweating, tremor, palpitations; neuroglycopenic: confusion, visual changes, seizure)
2. Documented low plasma glucose < 55 mg/dL (3.0 mmol/L) on a lab-measured sample (not just a glucometer - whole blood reads ~15% lower than plasma)
3. Resolution of symptoms after plasma glucose is raised

Do not pursue extensive investigation without Whipple's triad. Absence of symptoms during documented low glucose suggests artifactual hypoglycemia (e.g., delay in sample processing, polycythemia, leukocytosis). Collect blood in a fluoride-oxalate tube and analyze promptly.

• Washington Manual of Medical Therapeutics, p. 911
• Goldman-Cecil Medicine, p. 2495

Step 2 - Initial History-Directed Classification

Step 3 - Differential Diagnosis in This Patient

A. Hyperinsulinemic (most important to exclude)

B. Hormonal Deficiency

C. Drug-Induced (must always ask explicitly)

• Sulfonylureas, insulin (even if patient denies - check SFU metabolites in blood)
• Alcohol (inhibits hepatic gluconeogenesis)
• Salicylates, quinine, beta-blockers, pentamidine, fluoroquinolones

D. Systemic/Organ Failure

• Severe hepatic insufficiency (check LFTs, liver synthetic function)
• Renal failure (kidneys contribute to gluconeogenesis; impaired insulin clearance)
• Sepsis, starvation, eating disorders

E. Family History Context - The MODY Angle

1. MODY (Maturity-Onset Diabetes of the Young): Autosomal dominant monogenic diabetes. If the patient herself has mild fasting hyperglycemia rather than hypoglycemia, GCK-MODY is the most common stable form. However, activating mutations in GCK are a rare cause of hypoglycemia (the glucose setpoint is shifted down). Other MODY types (HNF4A, HNF1A) can present with hypoglycemia in infancy/childhood.
2. Risk of T2DM: First-degree family history of T2DM increases her own risk. However, T2DM itself would not explain hypoglycemia unless she is on antidiabetic medications.

Step 4 - Diagnostic Approach (Ketone-Based Algorithm)

Goldman-Cecil Medicine, Fig. 211-3

• Ketone-positive (≥2.7 mmol/L): Points toward counter-regulatory hormone deficiency (ACTH, cortisol, GH), organic acidemia, or glycogen storage disorder. Hyperinsulinism is less likely.
• Ketone-negative (<2.7 mmol/L): Suppressed ketogenesis suggests hyperinsulinism (insulin suppresses lipolysis and ketogenesis). Measure fatty acids next.
  • Low fatty acids → Hyperinsulinemic hypoglycemia (insulinoma, autoimmune, factitious)
  • High fatty acids → Fatty acid oxidation disorder or ketone synthesis disorder

Step 5 - Laboratory Investigations

Immediate (during a hypoglycemic episode or at the conclusion of the fast):

Additional:

Step 6 - Provocative/Confirmatory Tests

72-Hour Supervised Fast (gold standard for fasting hypoglycemia)

1. Start after last meal; stop interfering medications
2. Water permitted; patient active during waking hours
3. Blood for glucose, insulin, C-peptide, β-hydroxybutyrate every 6 hours until glucose <60 mg/dL, then every 1-2 hours
4. End the fast when: glucose ≤45 mg/dL with symptoms, or Whipple's triad already established with glucose ≤55 mg/dL, or 72 hours elapsed without hypoglycemia
5. At end: collect glucose, insulin, C-peptide, proinsulin, β-hydroxybutyrate, SFU screen → give IV glucagon 1 mg → measure glucose at 10, 20, 30 min (positive response = rise ≥25 mg/dL indicates hyperinsulinism with preserved hepatic glycogen)

Important note: Healthy thin/lean women may have plasma glucose as low as 40 mg/dL during a 72-hour fast without symptoms - this does not confirm a hypoglycemic disorder if Whipple's triad is absent.

Mixed-Meal Test (for postprandial symptoms)

• If symptoms occur 1-5 hours after meals, collect glucose, insulin, C-peptide, proinsulin every 30 minutes for 300 minutes after a meal similar to what triggers symptoms
• Positive: neuroglycopenic symptoms + glucose ≤50 mg/dL

Step 7 - Imaging (once biochemical hyperinsulinism confirmed)

• Multiphasic pancreatic CT or MRI pancreas - first line
• Endoscopic ultrasound (EUS) - detects small tumors not seen on CT
• 68Ga-DOTATATE PET-CT - for neuroendocrine tumors
• Selective arterial calcium stimulation test - if imaging negative, localizes functional hyperinsulinism to a pancreatic region

Key Clinical Reasoning Points for This Patient

1. Mother's diabetes does not directly cause this patient's hypoglycemia - but raises two specific concerns:
   • She may unknowingly be using her mother's antidiabetic medications (sulfonylurea screen mandatory)
   • Rare activating GCK mutations cause hypoglycemia and run in families with a "diabetic" phenotype (siblings may have hyperglycemia while she has hypoglycemia due to a different mutation)
2. A 40-year-old woman - insulinoma incidence peaks in the 4th-6th decades; the triad of hypoglycemic episodes, especially fasting, should trigger a 72-hour fast
3. Factitious hypoglycemia must always be considered - exogenous insulin gives suppressed C-peptide with elevated insulin; SFU gives elevated C-peptide and positive drug screen
4. Adrenal insufficiency is often overlooked in women this age and can be insidious

Summary Workup Algorithm

Whipple's Triad confirmed?
       ↓ Yes
Measure at time of hypoglycemia:
  Glucose + Insulin + C-peptide + Proinsulin + β-hydroxybutyrate + SFU screen
       ↓
β-OHB < 2.7 → Hyperinsulinism suspected
       ↓
72-hour fast (if fasting sx) or Mixed-meal test (if postprandial sx)
       ↓
Hyperinsulinism confirmed (Insulin ≥3 µU/mL, C-pep ≥200 pmol/L)?
  → Check insulin antibodies → if negative → imaging for insulinoma
  → C-peptide suppressed? → factitious (exogenous insulin)
  → SFU positive? → drug-induced
       ↓
β-OHB > 2.7 → Hormonal deficiency workup (cortisol, ACTH stim, GH, TFTs)

• Washington Manual of Medical Therapeutics, p. 911 (Evaluation of hypoglycemia without diabetes)
• Goldman-Cecil Medicine, 2-Vol Set, pp. 2491-2497 (Differential diagnosis and evaluation protocol)
• Tietz Textbook of Laboratory Medicine 7th Ed., p. 1135 (Prolonged fast protocol)